REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

Part of paid clinical trials in Buffalo, New York.

Sponsor
Medtronic Neurovascular Clinical Affairs
Study ID
NCT07599904
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Device: Mechanical Thrombectomy — PROCEDURE
    Index stroke procedure and follow-up visits up to 90 days post index procedure

Study Details

Post-Market Registry

Key Dates

Start date
May 31, 2026
Status verified
May 2026
Primary completion
Jul 31, 2031
Completion
Jul 31, 2031

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

Evaluate device safety [ Time Frame: From Day 0 to 90 days post-procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Buffalo General Medical CenterBuffaloNew York14203
Jason Davies, MD
[email protected]
716-218-1000

Find similar trials in Buffalo, NY

By condition
Stroke
By specialty
NeurologyBrain disorders
By research site
Buffalo General Medical Center· Buffalo, NY

Related Studies